Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Xerostomia (Dry Mouth) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Xerostomia (Dry Mouth) Therapeuticsmarket, defines the market attractiveness level of Xerostomia (Dry Mouth) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Xerostomia (Dry Mouth) Therapeutics industry, describes the types of Xerostomia (Dry Mouth) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Xerostomia (Dry Mouth) Therapeutics market and the development prospects and opportunities of Xerostomia (Dry Mouth) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Xerostomia (Dry Mouth) Therapeutics market in Chapter 13.
By Player:
OraCoat
Sun Pharmaceuticals Industries Ltd
Pendopharm
Acacia Pharma
GlaxoSmithKline plc
Church & Dwight Co Inc
Hikma Pharmaceuticals PLC
Pfizer Inc
Parnell Pharmaceuticals Inc
Colgate-Palmolive Company
Lupin Pharmaceuticals Inc
By Type:
Salivary Stimulants
Salivary Substitutes
Dentifrices
By End-User:
OTC
Prescription
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Xerostomia (Dry Mouth) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Xerostomia (Dry Mouth) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Xerostomia (Dry Mouth) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Xerostomia (Dry Mouth) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Xerostomia (Dry Mouth) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
-
7.2 United States Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
-
7.3 Europe Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
-
7.4 China Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
-
7.5 Japan Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
-
7.6 India Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Xerostomia (Dry Mouth) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Xerostomia (Dry Mouth) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Xerostomia (Dry Mouth) Therapeutics Consumption Forecast (2022-2028)
9 Global Xerostomia (Dry Mouth) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Salivary Stimulants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Salivary Substitutes Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dentifrices Consumption and Growth Rate (2017-2022)
-
9.2 Global Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Prescription Consumption and Growth Rate (2017-2022)
10 Global Xerostomia (Dry Mouth) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Salivary Stimulants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Salivary Substitutes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dentifrices Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Prescription Consumption Forecast and Growth Rate (2022-2028)
11 Global Xerostomia (Dry Mouth) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Xerostomia (Dry Mouth) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Xerostomia (Dry Mouth) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Xerostomia (Dry Mouth) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Xerostomia (Dry Mouth) Therapeutics Market Competitive Analysis
-
14.1 OraCoat
-
14.1.1 OraCoat Company Details
-
14.1.2 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.2 Sun Pharmaceuticals Industries Ltd
-
14.2.1 Sun Pharmaceuticals Industries Ltd Company Details
-
14.2.2 Sun Pharmaceuticals Industries Ltd Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sun Pharmaceuticals Industries Ltd Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.3 Pendopharm
-
14.3.1 Pendopharm Company Details
-
14.3.2 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.4 Acacia Pharma
-
14.4.1 Acacia Pharma Company Details
-
14.4.2 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.5 GlaxoSmithKline plc
-
14.5.1 GlaxoSmithKline plc Company Details
-
14.5.2 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.6 Church & Dwight Co Inc
-
14.6.1 Church & Dwight Co Inc Company Details
-
14.6.2 Church & Dwight Co Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Church & Dwight Co Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.7 Hikma Pharmaceuticals PLC
-
14.7.1 Hikma Pharmaceuticals PLC Company Details
-
14.7.2 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Details
-
14.8.2 Pfizer Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.9 Parnell Pharmaceuticals Inc
-
14.9.1 Parnell Pharmaceuticals Inc Company Details
-
14.9.2 Parnell Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Parnell Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.10 Colgate-Palmolive Company
-
14.10.1 Colgate-Palmolive Company Company Details
-
14.10.2 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product and Service
-
14.11 Lupin Pharmaceuticals Inc
-
14.11.1 Lupin Pharmaceuticals Inc Company Details
-
14.11.2 Lupin Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Lupin Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Xerostomia (Dry Mouth) Therapeutics
-
Figure Xerostomia (Dry Mouth) Therapeutics Picture
-
Table Global Xerostomia (Dry Mouth) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Xerostomia (Dry Mouth) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Xerostomia (Dry Mouth) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Xerostomia (Dry Mouth) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Xerostomia (Dry Mouth) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Xerostomia (Dry Mouth) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Salivary Stimulants Consumption and Growth Rate (2017-2022)
-
Figure Global Salivary Substitutes Consumption and Growth Rate (2017-2022)
-
Figure Global Dentifrices Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription Consumption and Growth Rate (2017-2022)
-
Figure Global Salivary Stimulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Salivary Substitutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dentifrices Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Xerostomia (Dry Mouth) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Xerostomia (Dry Mouth) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table OraCoat (Foundation Year, Company Profile and etc.)
-
Table OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table OraCoat Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Sun Pharmaceuticals Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceuticals Industries Ltd Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceuticals Industries Ltd Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Pendopharm (Foundation Year, Company Profile and etc.)
-
Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Acacia Pharma (Foundation Year, Company Profile and etc.)
-
Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Church & Dwight Co Inc (Foundation Year, Company Profile and etc.)
-
Table Church & Dwight Co Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Church & Dwight Co Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Hikma Pharmaceuticals PLC (Foundation Year, Company Profile and etc.)
-
Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Parnell Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Parnell Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Parnell Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Colgate-Palmolive Company (Foundation Year, Company Profile and etc.)
-
Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product and Service
-
Table Lupin Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Lupin Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Pharmaceuticals Inc Xerostomia (Dry Mouth) Therapeutics Product and Service
-
